Audiologists in Palo Alto, CA Accepting Medicare

48 Audiologists found. Showing 41 - 48

Chi Mai Quynh Tran, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 2452 Watson Ct Ste 1500, Palo Alto, CA 94303 Phone: 650-497-8000

Dr. Rebekah Will, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1000 Welch Rd, Suite 10, Palo Alto, CA 94304 Phone: 650-498-2739

Kristina Marie Ward, AUD, PHD, CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000

Annie Colleen Vranesic, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1000 Welch Rd, Suite 10, Palo Alto, CA 94304 Phone: 650-498-4327

Chelsea Juneau, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2452 Watson Ct, Palo Alto, CA 94303 Phone: 650-498-4327

Ms. Anne Marie Yamashita, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 1000 Welch Rd Ste 10, Palo Alto, CA 94304 Phone: 650-498-4327    Fax: 650-736-4327

Laura Gail Street, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 795 El Camino Real, Palo Alto, CA 94301 Phone: 650-853-2952

Ms. Dorothy Ann Kelly, M.ED. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3801 Miranda Ave, Va Palo Alto Health Care System, Palo Alto, CA 94304 Phone: 650-493-5000    Fax: 650-849-0516

News Archive

Lupin receives approval for Amlodipine tablets

Lupin Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Amlodipine Besylate Tablets, 2.5 mg (base), 5 mg (base) and 10 mg (base).

Breast and ovarian cancer awareness campaign launched by Myriad Genetics

Myriad Genetics, Inc. (Nasdaq: MYGN) announced today that it has launched a hereditary breast and ovarian cancer Public Awareness Campaign in five Midwest states, including Illinois, Indiana, Kentucky, Missouri and Ohio. The initiative is a comprehensive effort designed to reach women with a family history of breast and/or ovarian cancers and the healthcare providers that treat them.

Discovery could lead to new leukaemia therapies

Human blood cells have olfactory receptors that respond to Sandalore. This could provide a starting point for new leukaemia therapies, as researchers from Bochum report in in the journal "Cell Death Discovery".

Uniquest, Aquavit Life Sciences announce MOU to form Alliance Partnership

Aquavit Life Sciences, Inc., a wholly owned subsidiary of Aquavit Pharmaceuticals, Inc., announces together with Uniquest Corporation (KOSPI: 077500) a Memorandum Of Understanding to form an Alliance Partnership for the development, registration and manufacturing of Aquavit Pharmaceuticals' PITO-001.

Boryung Pharmaceutical implements Cegedim Dendrite's Mobile Intelligence CRM solution

Cegedim Dendrite, the world's leading provider of Life Sciences-specific customer relationship management (CRM) solutions, announced today that Boryung Pharmaceutical Co., Ltd., has implemented Cegedim Dendrite's Mobile Intelligence™ CRM solution. Boryung Pharmaceutical is one of Korea's top 10 domestic pharmaceutical companies, and Cegedim Dendrite currently serves 14 of the industry's top-grossing companies in Korea.

Read more Medical News

› Verified 2 days ago

• 1
• 2
• 3(current)